SR biotek Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2016	FY 2015
Period Ending	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Net Income	-76.98	461.08
Depreciation & Amortization	249.35	189.85
Loss (Gain) From Sale of Assets	-	-78.19
Provision & Write-off of Bad Debts	2.07	-
Other Operating Activities	61.08	62.17
Change in Accounts Receivable	-27.09	11.7
Change in Inventory	53.57	-
Change in Accounts Payable	-12.02	34.36
Change in Income Taxes	-4.46	2.88
Change in Other Net Operating Assets	-88.54	-562.38
Operating Cash Flow	156.99	121.47
Operating Cash Flow Growth	29.24%	-
Capital Expenditures	-134.56	-1,653
Sale of Property, Plant & Equipment	-	307.7
Sale (Purchase) of Intangibles	-0.39	-
Sale (Purchase) of Real Estate	-	-247.72
Investment in Securities	-100.6	-0.6
Other Investing Activities	3.28	12.32
Investing Cash Flow	-241.48	-1,581
Long-Term Debt Issued	-	1,749
Long-Term Debt Repaid	-120.29	-238.39
Net Debt Issued (Repaid)	-120.29	1,511
Financing Cash Flow	-120.29	1,511
Miscellaneous Cash Flow Adjustments	-	-0
Net Cash Flow	-204.78	50.95
Free Cash Flow	22.43	-1,531
Free Cash Flow Margin	1.38%	-81.61%
Free Cash Flow Per Share	560.53	-38285.18
Levered Free Cash Flow	48.56	-
Unlevered Free Cash Flow	80.56	-
Change in Net Working Capital	66.06	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.